Health Care & Life Sciences » Pharmaceuticals | Fuji Pharma Co. Ltd.

Fuji Pharma Co. Ltd. | Cash Flow

Fiscal year is October-September. All values JPY Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
3,332
3,232
3,105
3,148
4,530
4,472
Depreciation, Depletion & Amortization
1,413
1,653
2,079
1,921
2,023
2,251
Other Funds
-
-
5
-
-
1,833
Funds from Operations
3,595
4,120
4,213
4,551
5,191
4,891
Changes in Working Capital
35
1,363
3,624
42
1,953
1,118
Net Operating Cash Flow
3,630
2,757
589
4,509
3,238
3,773
Capital Expenditures
3,326
2,021
1,543
3,806
1,661
Sale of Fixed Assets & Businesses
-
-
2,508
453
130
Purchase/Sale of Investments
39
-
-
10
-
Net Investing Cash Flow
6,601
1,975
999
3,319
1,534
Cash Dividends Paid - Total
522
593
675
674
704
Issuance/Reduction of Debt, Net
4,265
803
2,451
753
1,921
Net Financing Cash Flow
3,743
1,293
4,635
78
3,042
Net Change in Cash
844
2,158
3,015
1,150
1,311
Free Cash Flow
851
1,678
923
2,201
1,761
Net Assets from Acquisitions
3,386
-
-
-
-
Other Sources
72
46
36
46
-
Change in Capital Stock
-
2,689
1,504
-
-
Exchange Rate Effect
72
83
32
118
27
Other Uses
-
-
2
1
1

About Fuji Pharma Co.

View Profile
Address
Seito Kaikan, 6/F
Tokyo Tokyo 102
Japan
Employees -
Website http://www.fujipharma.jp
Updated 07/08/2019
Fuji Pharma Co., Ltd. engages in the development, manufacture and sale of pharmaceutical products. Its services include medical care for women in vitro diagnostics, sale of acute medical care products and curative medicine (injection agents), and provides information regarding pharmaceuticals and healthcare. The company products include injection agents, internal drugs, drugs for external use, diagnostic agent, hormonal agent, cardiovascular preparation, antibiotic drugs, chemotherapeutic agent, genitourinary related drugs, dermatological preparation and others.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.